When insiders speak, we transcribe.
Long-form, data-driven studies on 1.6M+ filings across 37 markets. Comparative regulation, walk-forward backtests, profiles, market mechanics.
Central Garden & Pet: Brown sells 3,900 shares as peers hold up
William E. Brown sold 3,900 Central Garden & Pet shares for EUR 152,100 while the pet and staples backdrop stays mixed and the cluster grows.
Chime’s August rally meets DST Global’s 12 sales
Chime traded near $31 to $32 after earnings, then DST Global Advisors filed 12 August 17 sales. Here is what that means for the setup.
AstraZeneca, healthcare inflows, and one routine grant
AstraZeneca trades with healthcare inflows and a fresh trial setback, while the only recent insider move was a small August 6 share grant.
Roger Blundell buys EUR 100,104 as SUPR lags peers
Supermarket Income REIT draws a fresh director buy from Roger Blundell as UK REITs firm, peers run ahead, and the grocery case stays defensive.
Wizz Air's £98,465 sale against easyJet's bid glow
Wizz Air's Acting Revenue Officer West sold £98,465 of stock after Q1 losses and fuel pressure, while easyJet trades with bid support.
HCL Technologies: 9 insider buys, 1 August 17 close
HCL Technologies drew 9 insider filings, mostly ESOS buys, as the stock slipped 2.57% on August 17. Here is the honest read.
Nine GSK insiders bought on 11 August at 1,934.96p
Nine GSK executives bought shares on 11 August at 1,934.96p. Read the cluster against healthcare valuations, AstraZeneca, and Pfizer.
Öresund’s two August 17 buys, and the Stockholm test
Two insiders bought Öresund on August 17 as Stockholm stayed soft. Here is what the filings add, and where the case gets thin.
Standard Chartered’s £22.09 and £22.48 sales, read in context
Standard Chartered’s CEO and COO sold shares after a strong half-year. Here is how the bank’s Asia-led model, peers and cluster data fit.
Hammerson’s 13 August buy lands after July’s £100k prints
Hammerson’s CEO added shares on 13 August after July’s larger buys. Read the filing against UK retail REIT strength, peer moves and the latest print.
Dr. Martens: CEO and CFO buy 179 shares each
Dr. Martens’ CEO and CFO bought 179 shares each as the brand holds guidance, while Burberry and JD Sports frame the sector backdrop.
Liam Condon buys 10 JMAT shares as BASF steadies
Johnson Matthey directors bought via SIP on 11 August while chemicals stay choppy, BASF steadies and JMAT trades near 2,190 GBX.